GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biosino Bio-Technology and Science Inc (HKSE:08247) » Definitions » Accounts Receivable

Biosino Bio-Technology and Science (HKSE:08247) Accounts Receivable : HK$195.6 Mil (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Biosino Bio-Technology and Science Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Biosino Bio-Technology and Science's accounts receivables for the quarter that ended in Dec. 2023 was HK$195.6 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Biosino Bio-Technology and Science's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 207.82.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Biosino Bio-Technology and Science's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was HK$-0.95.


Biosino Bio-Technology and Science Accounts Receivable Historical Data

The historical data trend for Biosino Bio-Technology and Science's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosino Bio-Technology and Science Accounts Receivable Chart

Biosino Bio-Technology and Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 246.91 242.52 254.01 240.66 195.57

Biosino Bio-Technology and Science Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 240.66 - 219.56 - 195.57

Biosino Bio-Technology and Science Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Biosino Bio-Technology and Science Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Biosino Bio-Technology and Science's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=195.565/85.871*91
=207.82

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Biosino Bio-Technology and Science's accounts receivable are only considered to be worth 75% of book value:

Biosino Bio-Technology and Science's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(69.357+0.75 * 195.565+0.5 * 66.075-362.967
-0-22.988)/144.707
=-0.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Biosino Bio-Technology and Science Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Biosino Bio-Technology and Science's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosino Bio-Technology and Science (HKSE:08247) Business Description

Traded in Other Exchanges
N/A
Address
No. 27 Chaoqian Road, Science and Technology Industrial Park, Changping District, Beijing, CHN, 102200
Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale, and distribution of in-vitro diagnostic (IVD) reagent products. the company's revenue is generated from customers located in Mainland China.
Executives
Beijing Enterprises Group Company Limited 2201 Interest of corporation controlled by you
Beijing Enterprises Holdings Limited 2101 Beneficial owner
Hk Zhixin Investment Co., Ltd. 2101 Beneficial owner
Li Dongfeng 2201 Interest of corporation controlled by you
Yan Kang 2201 Interest of corporation controlled by you
Qiu Zhe Feng 2201 Interest of corporation controlled by you
Hai Nan Zhi Xin Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Yun Nan Sheng Neng Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Li Yang Yi Xiong 2201 Interest of corporation controlled by you

Biosino Bio-Technology and Science (HKSE:08247) Headlines

No Headlines